Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SALOME: Hydromorphone vs Diacetylmorphine for Opioid Dependence
NCT01447212Phase 3Completed
- Sponsor
- University of British Columbia
- Start
- Dec 2011
- Primary completion
- Jun 2014
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of hydromorphone in opioid use disorder (OUD), sponsored by University of British Columbia. Started Dec 2011; status: completed.
02
Drugs
hydromorphone
03
Conditions
opioid use disorder (OUD)
Beyond the preview
Go deeper on NCT01447212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01447212.